Home600276 • SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.21B | 20.14% |
Operating expense | 4.11B | 14.94% |
Net income | 1.87B | 36.90% |
Net profit margin | 26.01 | 13.98% |
Earnings per share | — | — |
EBITDA | 2.21B | 34.12% |
Effective tax rate | 9.60% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.20B | 11.13% |
Total assets | 51.29B | 10.69% |
Total liabilities | 3.74B | -4.04% |
Total equity | 47.55B | — |
Shares outstanding | 6.25B | — |
Price to book | 6.98 | — |
Return on assets | 9.99% | — |
Return on capital | 10.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.87B | 36.90% |
Cash from operations | 555.17M | -55.75% |
Cash from investing | -531.68M | 29.15% |
Cash from financing | -661.06M | -3,545.30% |
Net change in cash | -607.94M | -229.94% |
Free cash flow | -1.27B | -13,096.51% |
Previous close
¥52.47
Day range
¥52.60 - ¥53.79
Year range
¥38.01 - ¥57.53
Market cap
334.71B CNY
Avg Volume
42.74M
P/E ratio
49.32
Dividend yield
0.38%
Primary exchange
SHA
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
1970
Website
Employees
20,325
